Source: EQ

BacterioScan: BacterioScan Receives FDA Clearance for Rapid Infection Detection System

BacterioScan, Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract Infection (UTI) detection system. The BacterioScan 216Dx system is a rapid automated diagnostic system for the detection of bacterial UTIs, one of the most common types of infection. Current UTI testing is [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Dana A. Marshall's photo - President & CEO of BacterioScan

President & CEO

Dana A. Marshall

CEO Approval Rating

68/100

Read more